Terms: = Kidney tumors AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
656 results:
1. [Total polyphenols of Cydonia oblonga inhibited proliferation and migration of renal cancer cells by PI3K/Akt/mTOR pathway].
Abudurousuli K; Han MY; Hailati S; Maihemuti N; Talihati Z; Nueraihemaiti N; Dilimulati D; Baishan A; Aikebaier A; Zhou WT
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1052-1063. PubMed ID: 38621912
[TBL] [Abstract] [Full Text] [Related]
2. Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas.
Roskoski R
Pharmacol Res; 2024 May; 203():107181. PubMed ID: 38614375
[TBL] [Abstract] [Full Text] [Related]
3. Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour.
Wang H; Zhang Y
Arch Esp Urol; 2024 Mar; 77(2):135-141. PubMed ID: 38583005
[TBL] [Abstract] [Full Text] [Related]
4. Histomorphometric and Immunohistochemical Diagnosis of Renal Cell Carcinoma: Review Article.
Deka D; Chakravarty M
Mymensingh Med J; 2024 Apr; 33(2):636-642. PubMed ID: 38557550
[TBL] [Abstract] [Full Text] [Related]
5. SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc.
Jiang M; Huang Z; Chen L; Deng T; Liu J; Wu Y
BMC Cancer; 2024 Mar; 24(1):386. PubMed ID: 38532359
[TBL] [Abstract] [Full Text] [Related]
6. Nilotinib in kit-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Larkin J; Marais R; Porta N; Gonzalez de Castro D; Parsons L; Messiou C; Stamp G; Thompson L; Edmonds K; Sarker S; Banerji J; Lorigan P; Evans TRJ; Corrie P; Marshall E; Middleton MR; Nathan P; Nicholson S; Ottensmeier C; Plummer R; Bliss J; Valpione S; Turajlic S
Cell Rep Med; 2024 Mar; 5(3):101435. PubMed ID: 38417447
[TBL] [Abstract] [Full Text] [Related]
7. SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
Wu Y; Chen W; Miao H; Xu T
BMC Cancer; 2024 Feb; 24(1):210. PubMed ID: 38360598
[TBL] [Abstract] [Full Text] [Related]
8. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
9. Integrated single-cell and bulk characterization of branched chain amino acid metabolism-related key gene BCAT1 and association with prognosis and immunogenicity of clear cell renal cell carcinoma.
Zheng J; Liu Y; Wang J; Shi J; Li L; Jiang X; Tao L
Aging (Albany NY); 2024 Feb; 16(3):2715-2735. PubMed ID: 38309289
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Recurrent Gastric GIST Who Survived for Long after Laparoscopic Resection and Imatinib Therapy].
Yabe N; Takenoya T; Oto I; Harada Y; Kondo A; Ogiso M; Maeda H; Asada Y; Sako H; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1718-1720. PubMed ID: 38303184
[TBL] [Abstract] [Full Text] [Related]
11. Identification of an immune-related eRNA prognostic signature for clear cell renal cell carcinoma.
Lv Y; Niu L; Li Q; Shao W; Yan X; Li Y; Yue Y; Chen H
Aging (Albany NY); 2024 Jan; 16(3):2232-2248. PubMed ID: 38289619
[TBL] [Abstract] [Full Text] [Related]
12. Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
Meng X; Li W; Yu T; Lu F; Wang C; Yuan H; Yang W; Dong W; Xiao W; Zhang X
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129636. PubMed ID: 38272402
[TBL] [Abstract] [Full Text] [Related]
13. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract] [Full Text] [Related]
14. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Crotonylation Metabolism Signature Predicting Overall Survival for Clear Cell Renal Cell Carcinoma.
Zheng J; Liu Y; Wei K; Shi J; Li L; Jiang X; Tao L
Int J Clin Pract; 2023; 2023():5558034. PubMed ID: 38058677
[TBL] [Abstract] [Full Text] [Related]
16. Celastrol enhances TRAIL‑R2‑mediated apoptosis and cytotoxicity in human renal cell carcinoma cells in caspase‑dependent manner.
Bao Y; Wu X; Kanematsu A; Kita Y; Kobayashi T; Kakehi Y; Yamamoto S
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37997857
[TBL] [Abstract] [Full Text] [Related]
17. Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma.
Zhang Y; Zhu YY; Chen Y; Zhang L; Wang R; Ding X; Zhang H; Zhang CY; Zhang C; Gu WJ; Wang C; Wang JJ
Clin Chim Acta; 2024 Jan; 552():117672. PubMed ID: 37995985
[TBL] [Abstract] [Full Text] [Related]
18. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
19. Resveratrol affects ccRCC cell senescence and macrophage polarization by regulating the stability of CCNB1 by RBM15.
Chen Z; Liu C; Ye T; Zhang Y; Chen Y
Epigenomics; 2023 Sep; 15(18):895-910. PubMed ID: 37909116
[No Abstract] [Full Text] [Related]
20. Diagnostic Utility of EMA, Vimentin and cd117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
Nwadiokwu JI; Adegoke OO; Ajani MA; Okolo CA; Awosusi BL; Okebalama VC
West Afr J Med; 2023 Oct; 40(10):1035-1040. PubMed ID: 37906498
[TBL] [Abstract] [Full Text] [Related]
[Next]
